These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Quantitative studies using positron emission tomography (PET) for the diagnosis and therapy planning of oncological patients. Dimitrakopoulou-Strauss A; Strauss L Hell J Nucl Med; 2006; 9(1):10-21. PubMed ID: 16617388 [TBL] [Abstract][Full Text] [Related]
4. Quantification in clinical fluorodeoxyglucose positron emission tomography. Hallett WA Nucl Med Commun; 2004 Jul; 25(7):647-50. PubMed ID: 15208490 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer. Ozawa Y; Hara M; Sakurai K; Nakagawa M; Tamaki T; Nishio M; Shibamoto Y Acta Radiol; 2010 Mar; 51(2):150-5. PubMed ID: 20092375 [TBL] [Abstract][Full Text] [Related]
6. Comparison of diffusion-weighted MRI and 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for detecting primary colorectal cancer and regional lymph node metastases. Ono K; Ochiai R; Yoshida T; Kitagawa M; Omagari J; Kobayashi H; Yamashita Y J Magn Reson Imaging; 2009 Feb; 29(2):336-40. PubMed ID: 19161185 [TBL] [Abstract][Full Text] [Related]
7. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography. Bar-Shalom R; Kagna O; Israel O; Guralnik L Cancer; 2008 Dec; 113(11):3213-21. PubMed ID: 18924145 [TBL] [Abstract][Full Text] [Related]
8. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298 [TBL] [Abstract][Full Text] [Related]
9. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer? Schaefferkoetter JD; Carlson ER; Heidel RE J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746 [TBL] [Abstract][Full Text] [Related]
10. [Malignant tumor with false negative 18F-FDG PET image]. Dong MJ; Lin XT; Zhao J; Guan YH; Zuo CT; Chen X; Dai JZ; Jiang BD Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383 [TBL] [Abstract][Full Text] [Related]
11. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of noise adaptive non-linear gaussian filter in FDG-PET study. Nagayoshi M; Murase K; Fujino K; Uenishi Y; Kawamata M; Nakamura Y; Kitamura K; Higuchi I; Oku N; Hatazawa J Ann Nucl Med; 2005 Sep; 19(6):469-77. PubMed ID: 16248383 [TBL] [Abstract][Full Text] [Related]
13. From tumor biology to clinical Pet: a review of positron emission tomography (PET) in oncology. Kubota K Ann Nucl Med; 2001 Dec; 15(6):471-86. PubMed ID: 11831394 [TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
15. The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions. Lan XL; Zhang YX; Wu ZJ; Jia Q; Wei H; Gao ZR Clin Radiol; 2008 Jul; 63(7):756-64. PubMed ID: 18555033 [TBL] [Abstract][Full Text] [Related]
16. [The value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) in diagnosis of neoplastic diseases]. Ruiz Hernández G; Romero de Avila Y Avalos C; Carreras Delgado JL Med Clin (Barc); 2005 Feb; 124(6):229-36. PubMed ID: 15737307 [TBL] [Abstract][Full Text] [Related]
17. Analysis of 2-[Fluorine-18]-Fluoro-2-deoxy-D-glucose uptake kinetics in PET studies of pulmonary inflammation. Schroeder T; Melo MF; Venegas JG Acad Radiol; 2011 Apr; 18(4):418-23. PubMed ID: 21292507 [TBL] [Abstract][Full Text] [Related]
18. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system. Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression. Yamada A; Oguchi K; Fukushima M; Imai Y; Kadoya M Ann Nucl Med; 2006 Nov; 20(9):597-604. PubMed ID: 17294670 [TBL] [Abstract][Full Text] [Related]
20. Clinical value of combined positron emission tomography/computed tomography imaging in the interpretation of 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography studies in cancer patients. Yeung HW; Schöder H; Smith A; Gonen M; Larson SM Mol Imaging Biol; 2005; 7(3):229-35. PubMed ID: 15912427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]